Skip to content
2000
Volume 22, Issue 3
  • ISSN: 1570-1638
  • E-ISSN: 1875-6220

Abstract

Cannabinoids are compounds with increasing scientific interest, particularly due to their interaction with the endocannabinoid system CBR1 and CBR2 receptors. They can interfere with appetite, pain, and sleep or develop mood changes in the individual. Cannabidiol (CBD) is a well-known cannabinoid with potential benefits, including reducing epilepsy seizures, alleviating anxiety and obsessive-compulsive disorder (OCD) symptoms, aiding in Tourette Syndrome (a neurodevelopmental disorder), depression, sleep disorders, and promising in the treatment of cancer, pain relief, and heart health. Although generally safe, CBD can have side effects, including drug metabolism interference, fertility, and liver function. In addition, it can be administered by oral, sublingual, transdermal, or inhalation each one with different bioavailability. The application of nanotechnology, specifically through colloidal carrier systems, holds promising potential for maximizing CBD's efficacy and pharmacological profile. There are reported CBD extraction methods using ethanol, carbon dioxide, deionised water, and non-polar oils like olive or coconut oil. Green extraction methods have gained popularity due to their higher yields, shorter extraction time, and reduced costs. A specific dose with the desired effects is challenging due to individual factors, with most studies suggesting a range between less than 1 and 50 mg/kg/d. This review aims to explore the principles of CBD-based products development, focusing on extraction methods and purification processes of this cannabinoid for tinctures, topicals, and other pharmaceutical forms, as well as further research to attain the objectives.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cddt/10.2174/0115701638305553240529103622
2024-06-06
2025-09-03

  • From This Site

    /content/journals/cddt/10.2174/0115701638305553240529103622
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. NarouzeS.N. Cannabinoids and pain: Mechanisms of action.Cannabinoids and Pain. NarouzeS.N. ChamSpringer International Publishing202119120410.1007/978‑3‑030‑69186‑8_24
     [Google Scholar]
  2. ŚledzińskiP. Nowak-TerpiłowskaA. ZeylandJ. Cannabinoids in medicine: Cancer, immunity, and microbial diseases.Int. J. Mol. Sci.202022126310.3390/ijms2201026333383838
     [Google Scholar]
  3. AbyadehM. GuptaV. PauloJ.A. GuptaV. ChitranshiN. GodinezA. SaksD. HasanM. AmirkhaniA. McKayM. SalekdehG.H. HaynesP.A. GrahamS.L. MirzaeiM. A proteomic view of cellular and molecular effects of cannabis.Biomolecules20211110141110.3390/biom1110141134680044
     [Google Scholar]
  4. SoderstromK. SolimanE. Van DrossR. Cannabinoids modulate neuronal activity and cancer by CB1 and CB2 receptor-independent mechanisms.Front. Pharmacol.2017872010.3389/fphar.2017.0072029066974
     [Google Scholar]
  5. DiLonardoM.J. CBD vs. THC: What’s the Difference?2019Available from: https://www.webmd.com/pain-management/cbd-thc-difference
  6. JohnsonJ. CBD oil for pain management: Effects, benefits, and uses.2020Available from: https://www.medicalnewstoday.com/articles/319475#what-is-cbd-oil
    [Google Scholar]
  7. CBD oil for pain: What the research shows.2021Available from: https://www.openaccessgovernment.org/cbd-oil-for-pain-what-the-research-shows/113198
  8. SkelleyJ.W. DeasC.M. CurrenZ. EnnisJ. Use of cannabidiol in anxiety and anxiety-related disorders.J. Am. Pharm. Assoc.202060125326110.1016/j.japh.2019.11.00831866386
     [Google Scholar]
  9. WieckiewiczG. StokłosaI. StokłosaM. GorczycaP. PudloR. Cannabidiol (CBD) in the self-treatment of depression-exploratory study and a new phenomenon of concern for psychiatrists.Front. Psychiatry20221383794610.3389/fpsyt.2022.83794635392393
     [Google Scholar]
  10. OberbarnscheidtT. MillerN.S. The impact of cannabidiol on psychiatric and medical conditions.J. Clin. Med. Res.202012739340310.14740/jocmr415932655732
     [Google Scholar]
  11. SicilianoC. BartellaL. MazzottiF. AielloD. NapoliA. De LucaP. TemperiniA. 1 H NMR quantification of cannabidiol (CBD) in industrial products derived from Cannabis sativa L. (hemp) seeds.IOP Conf. Series Mater. Sci. Eng.2019572101201010.1088/1757‑899X/572/1/012010
     [Google Scholar]
  12. RadwanM.M. ChandraS. GulS. ElSohlyM.A. Cannabinoids, phenolics, terpenes and alkaloids of Cannabis. Molecules2021269277410.3390/molecules2609277434066753
     [Google Scholar]
  13. MandalA. What are Cannabinoids?News-Medical2019Available from: https://www.news-medical.net/health/What-are-Cannabinoids.aspx
    [Google Scholar]
  14. KicmanA. ToczekM. The effects of cannabidiol, a non-intoxicating compound of cannabis, on the cardiovascular system in health and disease.Int. J. Mol. Sci.20202118674010.3390/ijms2118674032937917
     [Google Scholar]
  15. GorelickD.A. Cannabis-related disorders and toxic effects.N. Engl. J. Med.2023389242267227510.1056/NEJMra221215238091532
     [Google Scholar]
  16. MoralesP. HurstD.P. ReggioP.H. Molecular Targets of the Phytocannabinoids: A Complex Picture.Springer International Publishing201710313110.1007/978‑3‑319‑45541‑9_4
     [Google Scholar]
  17. AL UbeedH.M.S. BhuyanD.J. AlsherbinyM.A. BasuA. VuongQ.V. A comprehensive review on the techniques for extraction of bioactive compounds from medicinal cannabis.Molecules202227360410.3390/molecules2703060435163863
     [Google Scholar]
  18. BieB. WuJ. FossJ.F. NaguibM. An overview of the cannabinoid type 2 receptor system and its therapeutic potential.Curr. Opin. Anaesthesiol.201831440741410.1097/ACO.000000000000061629794855
     [Google Scholar]
  19. Use of Hemp (Cannabis sativa) and/or CBD (cannabidiol) in food.2021Available from: https://www.asae.gov.pt/newsletter2/asaenews-n-124-novembro-2021/uso.aspx
  20. Hemp Production | Sector Notes | Agricultural Markets | Production and markets.Office of Planning, Policies and General Administration2022
     [Google Scholar]
  21. Use of cannabis and its derivatives in cosmetic products.INFARMED20223
     [Google Scholar]
  22. FisherR.S. AcevedoC. ArzimanoglouA. BogaczA. CrossJ.H. ElgerC.E. EngelJ.Jr ForsgrenL. FrenchJ.A. GlynnM. HesdorfferD.C. LeeB.I. MathernG.W. MoshéS.L. PeruccaE. SchefferI.E. TomsonT. WatanabeM. WiebeS. ILAE official report: A practical clinical definition of epilepsy.Epilepsia201455447548210.1111/epi.1255024730690
     [Google Scholar]
  23. EPIDIOLEX® (cannabidiol). 2018Available from: https://www.epidiolex.com
  24. PascualA. CBD drug Epidiolex approved for use in Europe, GW Pharmaceuticals says.Hemp Industry Daily2019
     [Google Scholar]
  25. Epidiolex: Highlights of prescribing information.2024Available from: https://www.epidiolex.com/sites/default/files/pdfs/1020/EPX-03633-1020_EPIDIOLEX_(cannabidiol)_USPI_v8.0.pdf
  26. Epilepsia e Canabidiol.2020Available from: https://epilepsia.pt/epilepsia-e-canabidiol
  27. YetmanD. CBD oil for seizures: Use, effectiveness, side effects, and more.2021Available from: https://www.healthline.com/health/cbd-oil-for-seizures#cbd-oil-for-seizures
  28. BlessingE.M. SteenkampM.M. ManzanaresJ. MarmarC.R. Cannabidiol as a potential treatment for anxiety disorders.Neurotherapeutics201512482583610.1007/s13311‑015‑0387‑126341731
     [Google Scholar]
  29. KayserR.R. SnorrasonI. HaneyM. LeeF.S. SimpsonH.B. The endocannabinoid system: A new treatment target for obsessive compulsive disorder?Cannabis Cannabinoid Res.201942778710.1089/can.2018.004932656342
     [Google Scholar]
  30. Can CBD help with my anxiety and depression? Anxiety and depression association of America.2019Available from: https://adaa.org/understanding-anxiety/cbd
  31. Obsessive-compulsive Disorder2018Available from: https://www.nimh.nih.gov/health/topics/obsessive-compulsive-disorder-ocd
    [Google Scholar]
  32. HuffstetlerC.M. CochranB. MayC.A. MaykutN. SilverC.R. CedenoC. FranckE. CoxA. FadoolD.A. Single cannabidiol administration affects anxiety-, obsessive compulsive-, object memory-, and attention-like behaviors in mice in a sex and concentration dependent manner.Pharmacol. Biochem. Behav.202322217349810.1016/j.pbb.2022.17349836455670
     [Google Scholar]
  33. MauzayD. LaFranceE.M. CuttlerC. Acute effects of cannabis on symptoms of obsessive-compulsive disorder.J. Affect. Disord.202127915816310.1016/j.jad.2020.09.12433049434
     [Google Scholar]
  34. BonaccorsoS. RicciardiA. ZanganiC. ChiappiniS. SchifanoF. Cannabidiol (CBD) use in psychiatric disorders: A systematic review.Neurotoxicology20197428229810.1016/j.neuro.2019.08.00231412258
     [Google Scholar]
  35. ValléeA. LecarpentierY. ValléeJ.N. Possible actions of cannabidiol in obsessive-compulsive disorder by targeting the WNT/β- catenin pathway.Mol. Psychiatry202227123024810.1038/s41380‑021‑01086‑133837269
     [Google Scholar]
  36. JankovicJ. Tics and tourette syndromePractical Neurology.20172224
     [Google Scholar]
  37. ArtukogluB.B. BlochM.H. The potential of cannabinoid-based treatments in tourette syndrome.CNS Drugs201933541743010.1007/s40263‑019‑00627‑130977108
     [Google Scholar]
  38. Tourette Association of America.2019Available from: https://tourette.org/research-medical/medical-marijuana/
  39. Müller-VahlK.R. Treatment of tourette syndrome with cannabinoids.Behav. Neurol.201327111912410.1155/2013/29426423187140
     [Google Scholar]
  40. MosleyP.E. Tetrahydrocannabinol and cannabidiol in tourette syndrome.NEJM Evidence202329EVIDoa230001210.1056/EVIDoa2300012
     [Google Scholar]
  41. HollandK. How to Try CBD for Depression.2019Available from: https://www.healthline.com/health/cbd-for-depression
    [Google Scholar]
  42. KaulM. ZeeP.C. SahniA.S. Effects of cannabinoids on sleep and their therapeutic potential for sleep disorders.Neurotherapeutics202118121722710.1007/s13311‑021‑01013‑w33580483
     [Google Scholar]
  43. CrippaJ.A. GuimarãesF.S. CamposA.C. ZuardiA.W. Translational investigation of the therapeutic potential of cannabidiol (CBD): Toward a new age.Front. Immunol.20189200910.3389/fimmu.2018.0200930298064
     [Google Scholar]
  44. MarshallL. REM sleep behavior disorder (RBD): Clues about brain diseases.2022Available from: https://www.webmd.com/sleep-disorders/story/REM-sleep-behavior-disorder-RBD
  45. ChagasM.H.N. EckeliA.L. ZuardiA.W. Pena-PereiraM.A. Sobreira-NetoM.A. SobreiraE.T. CamiloM.R. BergamaschiM.M. SchenckC.H. HallakJ.E.C. TumasV. CrippaJ.A.S. Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson’s disease patients: A case series.J. Clin. Pharm. Ther.201439556456610.1111/jcpt.1217924845114
     [Google Scholar]
  46. TiwariS. AtluriV. KaushikA. YndartA. NairM. Alzheimer’s disease: Pathogenesis, diagnostics, and therapeutics.Int. J. Nanomedicine2019145541555410.2147/IJN.S20049031410002
     [Google Scholar]
  47. BarbosaM.G.A. BarrosÉ.F.A. LimaG.R. SilvaG.F. SouzaP.G.V.D. The use of the Cannabidiol compound in the treatment of Alzheimer's disease (literature review).Res Soc Dev202098e44298607310.33448/rsd‑v9i8.6073
     [Google Scholar]
  48. Cannabis, CBD oil and dementia.2020Available from: https://www.alzheimers.org.uk/about-dementia/treatments/alternative-therapies/cannabis-cbd-oil-and-dementia
  49. CBD reduces plaque, improves cognition in model of familial Alzheimer's.2021Available from: https://www.sciencedaily.com/releases/2021/03/210309192548.htm
  50. KimS.H. YangJ.W. KimK.H. KimJ.U. YookT.H. A review on studies of marijuana for Alzheimer’s disease – focusing on CBD, THC.J. Pharmacopuncture201922422523010.3831/KPI.2019.22.03031970019
     [Google Scholar]
  51. AnooradhaUnni CBD for Alzheimer’s and Dementia | Hemppedia.Hemppedia2021
     [Google Scholar]
  52. YauG.T.Y. TaiW. ArnoldJ.C. ChanH.K. KwokP.C.L. Cannabidiol for the treatment of brain disorders: Therapeutic potential and routes of administration.Pharm. Res.20234051087111410.1007/s11095‑023‑03469‑136635488
     [Google Scholar]
  53. O’BrienK. Cannabidiol (CBD) in cancer management.Cancers202214488510.3390/cancers1404088535205633
     [Google Scholar]
  54. Metastatic cancer: When cancer spreads.2020Available from: https://www.cancer.gov/types/metastatic-cancer
  55. DarišB. Tancer VerbotenM. KnezŽ. FerkP. Cannabinoids in cancer treatment: Therapeutic potential and legislation.Bosn. J. Basic Med. Sci.2019191142310.17305/bjbms.2018.353230172249
     [Google Scholar]
  56. De VitaM.J. MaistoS.A. GilmourC.E. McGuireL. TarvinE. MoskalD. The effects of cannabidiol and analgesic expectancies on experimental pain reactivity in healthy adults: A balanced placebo design trial.Exp. Clin. Psychopharmacol.202230553654610.1037/pha000046534251840
     [Google Scholar]
  57. Cannabis (Marijuana) and cannabinoids: What you need to know.2019Available from: https://www.nccih.nih.gov/health/cannabis-marijuana-and-cannabinoids-what-you-need-to-know
  58. ZamberlettiE. MartinC.R. PatelV.B. PreedyV.R. Alterations of THC and CBD ratios and impact on cognition.Cannabis Use, Neurobiology, Psychology, and Treatment.Academic Press202318119110.1016/B978‑0‑323‑89862‑1.00007‑6
     [Google Scholar]
  59. ArguetaD.A. VenturaC.M. KivenS. SagiV. GuptaK. A balanced approach for cannabidiol use in chronic pain.Front. Pharmacol.20201156110.3389/fphar.2020.0056132425793
     [Google Scholar]
  60. UritsI. GressK. CharipovaK. HabibK. LeeD. LeeC. JungJ.W. KassemH. CornettE. PaladiniA. VarrassiG. KayeA.D. ViswanathO. Use of cannabidiol (CBD) for the treatment of chronic pain.Baillieres. Best Pract. Res. Clin. Anaesthesiol.202034346347710.1016/j.bpa.2020.06.00433004159
     [Google Scholar]
  61. JadoonK.A. TanG.D. O’SullivanS.E. A single dose of cannabidiol reduces blood pressure in healthy volunteers in a randomized crossover study.JCI Insight2017212e9376010.1172/jci.insight.9376028614793
     [Google Scholar]
  62. JohnsonJ.R. LossignolD. Burnell-NugentM. FallonM.T. An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics.J. Pain Symptom Manage.201346220721810.1016/j.jpainsymman.2012.07.01423141881
     [Google Scholar]
  63. HammellD.C. ZhangL.P. MaF. AbshireS.M. McIlwrathS.L. StinchcombA.L. WestlundK.N. Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis.Eur. J. Pain201620693694810.1002/ejp.81826517407
     [Google Scholar]
  64. StanleyC.P. HindW.H. O’SullivanS.E. Is the cardiovascular system a therapeutic target for cannabidiol?Br. J. Clin. Pharmacol.201375231332210.1111/j.1365‑2125.2012.04351.x22670794
     [Google Scholar]
  65. SultanS.R. MillarS.A. EnglandT.J. O’SullivanS.E. A systematic review and meta-analysis of the haemodynamic effects of cannabidiol.Front. Pharmacol.201788110.3389/fphar.2017.0008128286481
     [Google Scholar]
  66. AtalayS. Jarocka-KarpowiczI. SkrzydlewskaE. Antioxidative and anti-inflammatory properties of cannabidiol.Antioxidants2019912110.3390/antiox901002131881765
     [Google Scholar]
  67. HuestisM.A. SoliminiR. PichiniS. PacificiR. CarlierJ. BusardòF.P. Cannabidiol adverse effects and toxicity.Curr. Neuropharmacol.2019171097498910.2174/1570159X1766619060317190131161980
     [Google Scholar]
  68. HendersonR.G. LefeverT.W. HeintzM.M. TrexlerK.R. BorghoffS.J. Bonn-MillerM.O. Oral toxicity evaluation of cannabidiol.Food Chem. Toxicol.202317611377810.1016/j.fct.2023.11377837105391
     [Google Scholar]
  69. IfflandK. GrotenhermenF. An update on safety and side effects of cannabidiol: A review of clinical data and relevant animal studies.Cannabis Cannabinoid Res.20172113915410.1089/can.2016.003428861514
     [Google Scholar]
  70. SeltzerE.S. WattersA.K. MacKenzieD.Jr GranatL.M. ZhangD. Cannabidiol (CBD) as a promising anti-cancer drug.Cancers20201211320310.3390/cancers1211320333143283
     [Google Scholar]
  71. PeruccaE. BialerM. Critical aspects affecting cannabidiol oral bioavailability and metabolic elimination, and related clinical implications.CNS Drugs202034879580010.1007/s40263‑020‑00741‑532504461
     [Google Scholar]
  72. What to know about products containing cannabis and CBD.2020Available from: https://www.fda.gov/consumers/consumer-updates/what-you-need-know-and-what-were-working-find-out-about-products-containing-cannabis-or-cannabis
  73. HuestisM.A. Human cannabinoid pharmacokinetics.Chem. Biodivers.2007481770180410.1002/cbdv.20079015217712819
     [Google Scholar]
  74. ThomasF. Improving solubility of cannabinoids.Pharm. Technol.20204422729
     [Google Scholar]
  75. GrifoniL. VantiG. DonatoR. SaccoC. BiliaA.R. Promising nanocarriers to enhance solubility and bioavailability of cannabidiol for a plethora of therapeutic opportunities.Molecules20222718607010.3390/molecules2718607036144803
     [Google Scholar]
  76. LeJ. Drug Bioavailability.Merck Manuals Professional Edition2022
     [Google Scholar]
  77. WangC. DongC. LuY. FreemanK. WangC. GuoM. Digestion behavior, in vitro and in vivo bioavailability of cannabidiol in emulsions stabilized by whey protein-maltodextrin conjugate: Impact of carrier oil.Colloids Surf. B Biointerfaces202322311315410.1016/j.colsurfb.2023.11315436708645
     [Google Scholar]
  78. MazzettiC. FerriE. PozziM. LabraM. Quantification of the content of cannabidiol in commercially available e-liquids and studies on their thermal and photo-stability.Sci. Rep.2020101369710.1038/s41598‑020‑60477‑632111858
     [Google Scholar]
  79. CBD Bioavailability: What Does it Mean Why is it so Important? 2022Available from: https://dailycbd.com/en/cbd-bioavailability
  80. ChayasirisobhonS. Mechanisms of action and pharmacokinetics of cannabis.Perm. J.2021251310.7812/TPP/19.20033635755
     [Google Scholar]
  81. PubChem Compound Summary for CID 644019, Cannabidiol.2023Available from: https://pubchem.ncbi.nlm.nih.gov/compound/cannabidiol#section=Drug-Drug-Interactions
  82. HosseiniA. McLachlanA.J. LickliterJ.D. A phase I trial of the safety, tolerability and pharmacokinetics of cannabidiol administered as single-dose oil solution and single and multiple doses of a sublingual wafer in healthy volunteers.Br. J. Clin. Pharmacol.20218742070207710.1111/bcp.1461733075170
     [Google Scholar]
  83. TapfumaneyiP. Recent advances and future prospective of topical and transdermal delivery systems.Front. Drug Deliv.202221810.3389/fddev.2022.957732
     [Google Scholar]
  84. PaudelK.S. HammellD.C. AguR.U. ValivetiS. StinchcombA.L. Cannabidiol bioavailability after nasal and transdermal application: effect of permeation enhancers.Drug Dev. Ind. Pharm.20103691088109710.3109/0363904100365729520545522
     [Google Scholar]
  85. FlynnE. Pharmacokinetic Parameters.xPharm: The Comprehensive Pharmacology ReferenceElsevierNew York20071310.1016/B978‑008055232‑3.60034‑0
     [Google Scholar]
  86. DoktorovovaS GokceE OzyaziciM SoutoE.B Lipid matrix nanoparticles: Pharmacokinetics and biopharmaceutics.Curr. Nanosci.20095335837110.2174/157341309788921516
     [Google Scholar]
  87. MillarS.A. MaguireR.F. YatesA.S. O’SullivanS.E. Towards better delivery of cannabidiol (CBD).Pharmaceuticals202013921910.3390/ph1309021932872355
     [Google Scholar]
  88. SinghB. BandopadhyayS. KapilR. SinghR. katareO. Self-emulsifying drug delivery systems (SEDDS): Formulation development, characterization, and applications.Crit. Rev. Ther. Drug Carrier Syst.200926542745110.1615/CritRevTherDrugCarrierSyst.v26.i5.1020136631
     [Google Scholar]
  89. DavidM.N.V. AkhondiH. Emulsions.StatPearls.Treasure Island, FLStatPearls Publishing2023
     [Google Scholar]
  90. Che MarzukiN.H. WahabR.A. Abdul HamidM. An overview of nanoemulsion: Concepts of development and cosmeceutical applications.Biotechnol. Biotechnol. Equip.201933177979710.1080/13102818.2019.1620124
     [Google Scholar]
  91. ZhengH. ChenB. RaoJ. Nutraceutical potential of industrial hemp (Cannabis sativa L.) extracts: Physicochemical stability and bioaccessibility of cannabidiol (CBD) nanoemulsions.Food Funct.20221384502451210.1039/D1FO04433H35348145
     [Google Scholar]
  92. DonsìF. SessaM. MediouniH. MgaidiA. FerrariG. Encapsulation of bioactive compounds in nanoemulsion-based delivery systems.Procedia Food Sci.201111666167110.1016/j.profoo.2011.09.246
     [Google Scholar]
  93. StellaB. BarattaF. Della PepaC. ArpiccoS. GastaldiD. DosioF. Cannabinoid formulations and delivery systems: Current and future options to treat pain.Drugs202181131513155710.1007/s40265‑021‑01579‑x34480749
     [Google Scholar]
  94. NakanoY. TajimaM. SugiyamaE. SatoV.H. SatoH. Development of a novel nano­emulsion formulation to improve intestinal absorption of cannabidiol.Med. Cannabis Cannabinoids201921354210.1159/00049736134676332
     [Google Scholar]
  95. TranV.N. StrnadO. ŠumanJ. VeverkováT. SukupováA. CejnarP. HynekR. KronusováO. ŠachJ. KaštánekP. RumlT. ViktorováJ. Cannabidiol nanoemulsion for eye treatment – Anti-inflammatory, wound healing activity and its bioavailability using in vitro human corneal substitute.Int. J. Pharm.202364312320210.1016/j.ijpharm.2023.12320237406946
     [Google Scholar]
  96. AhmedB. RizwanullahM. MirS.R. AkhtarM.S. AminS. Development of cannabidiol nanoemulsion for direct nose to brain delivery: Statistical optimization, in vitro and in vivo evaluation.Biomed. Mater.202217606500910.1088/1748‑605X/ac926736108625
     [Google Scholar]
  97. DependenceE.C.D. Cannabidiol (CBD) critical review report.Geneva Publisher201828
     [Google Scholar]
  98. CaporuscioJ. What is the correct dosage of CBD?Medical News Today2020
     [Google Scholar]
  99. AgencyE.M. Epidyolex.2023Available from: https://www.ema.europa.eu/en/medicines/human/EPAR/epidyolex
  100. ShepardJ. CBD Dosage Calculator: How Much CBD Should I Take?2022Available from: https://dailycbd.com/en/cbd-dosage
    [Google Scholar]
  101. FergusonS. CBD Dosage: Figuring Out How Much to Take.2023Available from: https://www.healthline.com/health/cbd- dosage#how-much-to-take
    [Google Scholar]
  102. MillarS.A. StoneN.L. BellmanZ.D. YatesA.S. EnglandT.J. O’SullivanS.E. A systematic review of cannabidiol dosing in clinical populations.Br. J. Clin. Pharmacol.20198591888190010.1111/bcp.1403831222854
     [Google Scholar]
  103. LarsenC. ShahinasJ. Dosage, efficacy and safety of cannabidiol administration in adults: A systematic review of human trials.J. Clin. Med. Res.202012312914110.14740/jocmr409032231748
     [Google Scholar]
  104. MotiejauskaitėD. UllahS. KundrotaitėA. ŽvirdauskienėR. BakšinskaitėA. BarčauskaitėK. Isolation of biologically active compounds from Cannabis sativa L.Antioxidants202312599810.3390/antiox1205099837237864
     [Google Scholar]
  105. LazarjaniM.P. YoungO. KebedeL. SeyfoddinA. Processing and extraction methods of medicinal cannabis: A narrative review.J Cannabis Res2021313210.1186/s42238‑021‑00087‑934281626
     [Google Scholar]
  106. KargiliU. AytacE. Supercritical fluid extraction of cannabinoids (THC and CBD) from four different strains of cannabis grown in different regions.J. Supercrit. Fluids2022179105410
     [Google Scholar]
  107. RysJ. Winterization Steps.2019Available from: https://www.coleparmer.com/tech-article/dewaxing-oil-winterization-steps
    [Google Scholar]
  108. O’DriscollA. The pros and cons of cannabis ethanol extraction.Analytical Cannabis 2022Available from: https://www.analyticalcannabis.com/articles/the-pros-and-cons-of-cannabis-ethanol-extraction-312763
    [Google Scholar]
  109. ChenC. PanZ. Cannabidiol and terpenes from hemp – ingredients for future foods and processing technologies.J Future Foods20211211312710.1016/j.jfutfo.2022.01.001
     [Google Scholar]
  110. OleinikG. CBD extraction methods: CO2, ethanol, and more explained.2023Available from: https://cbdthinker.com/cbd-extraction-methods
  111. NuapiaY. TutuH. ChimukaL. CukrowskaE. Selective extraction of cannabinoid compounds from cannabis seed using pressurized hot water extraction.Molecules2020256133510.3390/molecules2506133532183432
     [Google Scholar]
  112. BaranauskaiteJ. MarksaM. IvanauskasL. VitkeviciusK. LiaudanskasM. SkyriusV. BaranauskasA. Development of extraction technique and GC/FID method for the analysis of cannabinoids in Cannabis sativa L. spp. santicha (hemp).Phytochem. Anal.202031451652110.1002/pca.291531943398
     [Google Scholar]
  113. MayfieldA. Subcritical versus supercritical CO2 extractions | Extraction Magazine.2018Available from: https://extractionmagazine.com/category/applied-technology/subcritical-versus-supercritical-co2-extraction
  114. WegglerB.A. SnowN.H. Inlets and sampling.Separation Science and Technology.Academic Press2020141203
     [Google Scholar]
  115. DelazarA. NaharL. HamedeyazdanS. SarkerS.D. Microwave-assisted extraction in natural products isolation.Methods Mol. Biol.20128648911510.1007/978‑1‑61779‑624‑1_522367895
     [Google Scholar]
  116. AddoP.W. SagiliS.U.K.R. BilodeauS.E. Gladu-GallantF.A. MacKenzieD.A. BatesJ. McRaeG. MacPhersonS. ParisM. RaghavanV. OrsatV. LefsrudM. Microwave- and ultrasound-assisted extraction of cannabinoids and terpenes from cannabis using response surface methodology.Molecules20222724880310.3390/molecules2724880336557949
     [Google Scholar]
  117. ChuaL.S. LatiffN.A. MohamadM. Reflux extraction and cleanup process by column chromatography for high yield of andrographolide enriched extract.J. Appl. Res. Med. Aromat. Plants201632647010.1016/j.jarmap.2016.01.004
     [Google Scholar]
  118. Your Complete Guide to CBD Rosin. Vermont Hempicurean.2021Available from: https://vthempicurean.com/blog/your-complete-guide-to-cbd-rosin
  119. LiuD. CBD Rosin: Top Uses, Benefits & Effects Explained.2021Available from: https://cheefbotanicals.com/cbd-concentrates/cannabidiol-rosin/#What_is_CBD_Rosin
    [Google Scholar]
  120. The types of cannabis extraction.INDIVA2019Available from: https://www.indiva.com/blog/cannabis-101/the-types-of-cannabis-extraction
    [Google Scholar]
  121. MundleS.O.C. KlugerR. Decarboxylation via addition of water to a carboxyl group: Acid catalysis of pyrrole-2-carboxylic acid.J. Am. Chem. Soc.200913133116741167510.1021/ja905196n19645466
     [Google Scholar]
  122. FellettiS. CompagninG. KraukeY. StephanS. GrecoG. BurattiA. ChenetT. De LucaC. CataniM. CavazziniA. Purification and isolation of cannabinoids: Current challenges and perspectives.LC GC Eur.2023360412213110.56530/lcgc.eu.jp5571c5
     [Google Scholar]
  123. FellettiS. De LucaC. BurattiA. BozzaD. CerratoA. CapriottiA.L. LaganàA. CavazziniA. CataniM. Potency testing of cannabinoids by liquid and supercritical fluid chromatography: Where we are, what we need.J. Chromatogr. A2021165146230410.1016/j.chroma.2021.46230434118531
     [Google Scholar]
  124. SiitonenJ. SainioT. KaspereitM. Theoretical analysis of steady state recycling chromatography with solvent removal.Separ. Purif. Tech.2011781213210.1016/j.seppur.2011.01.013
     [Google Scholar]
  125. SidanaJ. JoshiL.K. Recycle HPLC: A powerful tool for the purification of natural products.Chromatogr. Res. Int.201320131710.1155/2013/509812
     [Google Scholar]
  126. MadakaF. Extraction and isolation of high quantities of cannabidiol, cannabinol, and delta-9-tetrahydrocannabinol from Cannabis sativa L.Malays. J. Anal. Sci.202125515
     [Google Scholar]
  127. PanchalB. How To Take CBD products: 11 Different WaysHolland & Barrett.2022
     [Google Scholar]
  128. What are some of the best ways to take CBD? 2020Available from: https://www.medicalnewstoday.com/articles/best-cbd-for- pain-management
  129. Best way to take CBD oil: Tips to help you get the most of your oil.2021Available from: https://supremecbd.uk/blogs/news/best-way-to-take-cbd-oil
  130. How to Take CBD Oil - Ultimate guide on uses & dosages.2021Available from: https://www.cbdcentral.com/how-to-take-cbd-oil
  131. Team, 3 Best Ways to Take CBD Oil: A Beginner's Guide.Spinfuel2023
     [Google Scholar]
  132. JohnsonJ. CBD patches for pain: Chronic, nerve, back, and more.2020Available from: https://www.medicalnewstoday.com/articles/cbd-patches-for-pain
    [Google Scholar]
  133. BartnerL.R. McGrathS. RaoS. HyattL.K. WittenburgL.A. Pharmacokinetics of cannabidiol administered by 3 delivery methods at 2 different dosages to healthy dogs.Can. J. Vet. Res.201882317818330026641
     [Google Scholar]
/content/journals/cddt/10.2174/0115701638305553240529103622
Loading
Understanding the Potential of CBD for Health Benefits: An Overview
Current Drug Discovery Technologies 22, E060624230799 (2025); https://doi.org/10.2174/0115701638305553240529103622
/content/journals/cddt/10.2174/0115701638305553240529103622
/content/journals/cddt/10.2174/0115701638305553240529103622
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): bioavailability; Cannabidiol; cannabinoids; CBR1 and CBR2 receptor; nanotechnology; obsessive-compulsive disorder

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test